
Venkataraman Balasubramanian
Examiner (ID: 8143, Phone: (571)272-0662 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611 |
| Total Applications | 2999 |
| Issued Applications | 2024 |
| Pending Applications | 254 |
| Abandoned Applications | 724 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13986353
[patent_doc_number] => 20190062334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/054728
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054728 | Organic compounds | Aug 2, 2018 | Issued |
Array
(
[id] => 15985307
[patent_doc_number] => 10672993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Nitrogen-containing polycyclic compound and organic light emitting element using same
[patent_app_type] => utility
[patent_app_number] => 16/035360
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 19419
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035360 | Nitrogen-containing polycyclic compound and organic light emitting element using same | Jul 12, 2018 | Issued |
Array
(
[id] => 13898845
[patent_doc_number] => 20190038627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE
[patent_app_type] => utility
[patent_app_number] => 16/030818
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030818 | METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE | Jul 8, 2018 | Abandoned |
Array
(
[id] => 15930841
[patent_doc_number] => 20200157054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHOD FOR PREPARING PYRIMIDONE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/627966
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627966
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627966 | Method for preparing pyrimidone compound | Jul 2, 2018 | Issued |
Array
(
[id] => 14230443
[patent_doc_number] => 20190127394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => BODIPY DYES FOR BIOLOGICAL IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/017638
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017638 | BODIPY dyes for biological imaging | Jun 24, 2018 | Issued |
Array
(
[id] => 13507567
[patent_doc_number] => 20180305326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/016053
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16016053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/016053 | Disubstituted 1, 2, 4-triazine compound | Jun 21, 2018 | Issued |
Array
(
[id] => 13916513
[patent_doc_number] => 10202364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Forms and compositions of an ERK inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/009080
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 101
[patent_no_of_words] => 41359
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009080 | Forms and compositions of an ERK inhibitor | Jun 13, 2018 | Issued |
Array
(
[id] => 13443997
[patent_doc_number] => 20180273541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/003232
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003232 | Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors | Jun 7, 2018 | Issued |
Array
(
[id] => 14596761
[patent_doc_number] => 10351562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
[patent_app_type] => utility
[patent_app_number] => 16/000382
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5599
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000382 | Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound | Jun 4, 2018 | Issued |
Array
(
[id] => 14852019
[patent_doc_number] => 10414721
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-17
[patent_title] => Inhibitor of endocannabinoid cellular reuptake
[patent_app_type] => utility
[patent_app_number] => 15/996764
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 16796
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996764 | Inhibitor of endocannabinoid cellular reuptake | Jun 3, 2018 | Issued |
Array
(
[id] => 13589849
[patent_doc_number] => 20180346473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => FUSED BICYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/994222
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994222 | FUSED BICYCLIC COMPOUNDS | May 30, 2018 | Abandoned |
Array
(
[id] => 13944427
[patent_doc_number] => 10207968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Complexes of 1-methylcyclopropene with metal coordination polymer networks
[patent_app_type] => utility
[patent_app_number] => 15/986387
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 9295
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986387 | Complexes of 1-methylcyclopropene with metal coordination polymer networks | May 21, 2018 | Issued |
Array
(
[id] => 13576863
[patent_doc_number] => 20180339980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => THIOCARBAMATE PRODRUGS OF TOFACITINIB
[patent_app_type] => utility
[patent_app_number] => 15/986018
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986018 | Thiocarbamate prodrugs of tofacitinib | May 21, 2018 | Issued |
Array
(
[id] => 13251143
[patent_doc_number] => 10138250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
[patent_app_type] => utility
[patent_app_number] => 15/984900
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 40
[patent_no_of_words] => 7536
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984900 | Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt | May 20, 2018 | Issued |
Array
(
[id] => 13565813
[patent_doc_number] => 20180334454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/984855
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984855 | KRAS G12C inhibitors and methods of using the same | May 20, 2018 | Issued |
Array
(
[id] => 13565803
[patent_doc_number] => 20180334449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => PROCESS FOR THE PREPARATION OF PURE NILOTINIB AND ITS SALT
[patent_app_type] => utility
[patent_app_number] => 15/979849
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15979849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/979849 | Process for the preparation of pure nilotinib and its salt | May 14, 2018 | Issued |
Array
(
[id] => 14132231
[patent_doc_number] => 20190100505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => INHIBITORS OF BRUTON'S TYROSINE KINASE
[patent_app_type] => utility
[patent_app_number] => 15/980515
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980515
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/980515 | INHIBITORS OF BRUTON'S TYROSINE KINASE | May 14, 2018 | Abandoned |
Array
(
[id] => 13957853
[patent_doc_number] => 20190055270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby
[patent_app_type] => utility
[patent_app_number] => 15/977391
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977391 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | May 10, 2018 | Abandoned |
Array
(
[id] => 14454203
[patent_doc_number] => 10323053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Polydentate binuclear ring metal complexes and devices containing same
[patent_app_type] => utility
[patent_app_number] => 15/975590
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7344
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975590 | Polydentate binuclear ring metal complexes and devices containing same | May 8, 2018 | Issued |
Array
(
[id] => 16383163
[patent_doc_number] => 10807985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Compositions useful for treating disorders related to kit
[patent_app_type] => utility
[patent_app_number] => 15/973378
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24744
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/973378 | Compositions useful for treating disorders related to kit | May 6, 2018 | Issued |